ArticleFrontiers in immunology2023

Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma.

Zhanqi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.